Key result
Intravenous gamma globulin did not reduce short-term mortality compared to conventional therapy alone in children with acute viral myocarditis.
Why the study?
Does intravenous gamma globulin improve survival and left ventricular ejection fraction in children with acute viral myocarditis?
Cohort (n=36)
No
Does intravenous gamma globulin improve survival and left ventricular ejection fraction in children with acute viral myocarditis?
In a retrospective cohort of children with acute viral myocarditis, the addition of IVIG to conventional therapy did not significantly improve short-term survival or mid-term LVEF recovery, though sicker patients were more likely to receive IVIG.
Answers are grounded in this paper and cite their sources.
IVIG should not yet change practice in pediatric viral myocarditis; leaves open efficacy for randomized trials.
Acute viral myocarditis is an extremely diverse disease with a predictable good outcome with supportive therapy. The objective of this study was to look at the clinical outcome of patients receiving additional intravenous gamma globulin compared to those receiving conventional anti-congestive therapy alone. Patients and methods: This is a retrospective review of charts of children admitted with acute myocarditis. Group 1 was children who received intravenous gamma globulin (IVIG) along with conventional anti-congestive therapy. Group 2 were patients who received the conventional anticongestive therapy alone. Short-term outcome was survival to hospital discharge, and mid-term outcome was improvement of left ventricular ejection fraction at 6 months and one year follow-up. Results: A total of 36 patients were enrolled and 18 were males. The mean age of all patients was 2.3 ± 2.6 years and the mean duration of illness for the whole group was 6.7 ± 3.8 days. Group 1 comprised of 16 patients. There was no difference in short-term outcome with mortality of 2 patients in Group1 (12.5%) and 3(15%) in Group 2 (p = 0.2). At intermediate term follow up, recovery of ejection fraction in Group 1 was in 4/14 (28%) and in Group 2 it was 9/17 (55%) and at 12 months it was 10/13 (77%) in Group 1 and 15/16 (94%) in Group 2 (p = 0.02 and 0.19 respectively). Conclusion: Acute myocarditis has a high spontaneous cure rate. Our study did not show any significant difference in the short-term or midterm outcome between children receiving IVIG compared to those who did not.
No takes yet. Share an insight, caveat, or question.
Atiq et al. (2014) conducted a cohort in Acute viral myocarditis (n=36). Intravenous gamma globulin (IVIG) vs. Conventional anti-congestive therapy alone was evaluated on Mortality prior to hospital discharge (p=0.2). Intravenous gamma globulin did not reduce short-term mortality compared to conventional therapy alone in children with acute viral myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: